Video

Understanding C Difficile Infections

Author(s):

The State of the Science events allows experts to come together to update on recent research for CDI.

It is an interesting and important time for clostridium difficile infection (CDI) research, as the spread may be increasing, but new microbiome live therapeutics may be soon on the horizon.

With research and our understanding on the infectious disease changing almost daily it is important for investigators, doctors, and stakeholders to come together to share knowledge and theories whenever possible.

Recently, Teena Chopra, MD, MPH, Wayne State University, headlined HCPLive’s State of Science Program called Institutional Perspectives in Infectious Diseases: Management of C. Difficile.

Chopra was joined by Ammara Mushtaq, MD, Wayne State University, Bhagyashri Navalkele, MD, UMMC, and Avnish Sandhu, DO, Wayne State University.

The discussion included presentations on understanding C difficile infections, standards of care, emerging treatments, and an update on managing the disease.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
© 2024 MJH Life Sciences

All rights reserved.